MBZ also triggers G2/M cell cycle arrest, down-regulates cancer stem cell markers, and exerts its effects via the Girdin-driven Akt/IKKα/β/NF-κB signaling axis, representing a novel mechanism of action. The gene discussed is CCDC88A; the disease is cancer.